Resources

Your trusted leader in GI/Liver testing services.

Myeloid68 uses targeted next-generation sequencing (NGS) to detect somatic alterations in 68 genes associated with myeloid malignancies.

Your trusted leader in genitourinary testing services.

GoPath Laboratories offers a complete testing solution for your CLL patients, including morphology, flow cytometry, FISH, cytogenetics, lgVH testing, B-cell receptor stereotyping, and minimal residual disease monitoring.

Patients. Results. Answers.

Molecular, FISH, Flow Cytometry, Histology, Cytology

BRCANOW® is a next-generation sequencing panel for people with a personal or family history of breast or ovarian cancer.

LYNCHNOW® is a germline screening tool to test for Lynch syndrome and other hereditary cancer disorders in patients with colorectal cancer.

PROSTATENOW™ is a genetic test for men with prostate cancer or those at risk of developing prostate cancer.

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer.

Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.

Prostate cancer is one of the most common forms of cancer, and studies show that inherited factors account for 57% of the risk for developing prostate cancer.

Genetic factors associated with prostate cancer conversion from active surveillance to treatment.

ProstateNow™ is a clinical grade comprehensive germline panel offered by GoPath Diagnostics.

BRCANow is a Next-Gen Sequencing (NGS)-based assay using a state-of-the-art platform developed exclusively at GoPath Laboratories.

Brian T. Helfand, MD, PhD. Division Head of Urology – NorthShore Medical Group.

Jianfeng Xu, DrPH. Vice President, Translational Research. Director, Program for Personalized Cancer Care.

Jim Lu MD, PhD. President, CEO and Medical Director. 15+ Years of Experience in GI and Liver Pathology.

We provide patients with information, support, and resources to better understand the risks and interpretation of genetics as it relates to cancer.

Dani Bishay, MS, CGC. Certified Genetic Counselor. 10+ Years in Genetic Counseling.

Scott M. Weissmann, MS, CGC. Certified Genetic Counselor. 15+ Years in Genetic Counseling.

TinaMarie Bauman RN, MSN, APN, AGN-BC. Hereditary Cancer Genetics Nurse. 20+ Years of Experience in Genetics Counseling and Oncology Nursing.

Bringing solutions to genetic testing. GoPath's GeneticsNow® Series includes a collection of next-generation sequencing panels that detect germline variants associated with an increased risk for various hereditary cancers.

GoPath offers a comprehensive step-by-step and cost-effective lynch screening program.

A Comprehensive Germline Panel for Prostate Cancer.

The core of germline testing is to know which genes/mutations have clinical validity and utility. The genes tested in ProstateNow™ are based on a combination of clinical guidelines and up-to-date evidence-based review.

OncoTarget® 500 is a comprehensive genomic profiling panel that analyzes over 500 genes to detect genomic alterations known to alter cancer growth.

Next-Generation Sequencing Concordance Analysis of Comprehensive Solid Tumor Profiling between a Centralized Specialty Laboratory and the Decentralized Personal Genome Diagnostics elio Tissue Complete Kitted Solution.

FDA-Cleared IVD Comprehensive Genomic Profiling Panel.

Genomic Profiling Powered by GoPath Diagnostics.

Unique Advantages of OncoTarget500®. Fast. Proven. Actionable.

Monitor Treatments. Early Treatment. Track.